Corcept Therapeutics (CORT) Asset Utilization Ratio (2013 - 2026)

Corcept Therapeutics (CORT) has 14 years of Asset Utilization Ratio data on file, last reported at 0.93 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 14.61% year-over-year to 0.93; the trailing twelve-month figure through Mar 2026 stood at 0.93 (up 14.61% YoY), and the FY2025 full-year result was 0.91, down 1.67% from the prior year.
• Asset Utilization Ratio advanced to 0.93 in Q1 2026, from 0.92 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.93 in Q1 2026 to a low of 0.69 in Q1 2023.
• A 5-year average of 0.82 and a median of 0.82 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio surged 40.93% in 2022 and decreased 19.2% in 2023, its largest moves.
• Tracing CORT's Asset Utilization Ratio over 5 years: stood at 0.72 in 2022, then climbed by 10.27% to 0.79 in 2023, then grew by 4.69% to 0.83 in 2024, then rose by 10.39% to 0.92 in 2025, then climbed by 1.54% to 0.93 in 2026.
• Business Quant data shows CORT's Asset Utilization Ratio at 0.93 in Q1 2026, 0.92 in Q4 2025, and 0.91 in Q3 2025.